Saxenda and Injection site bruising - a phase IV clinical study of FDA data

Summary:

Injection site bruising is found among people who take Saxenda, especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Saxenda and have Injection site bruising. It is created by eHealthMe based on reports of 4,905 people who have side effects when taking Saxenda from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

4,905 people reported to have side effects when taking Saxenda.
Among them, 93 people (1.9%) have Injection site bruising.

What is Saxenda?

Saxenda has active ingredients of liraglutide recombinant. It is often used in weight loss. eHealthMe is studying from 5,234 Saxenda users for its effectiveness, alternative drugs and more.

What is Injection site bruising?

Injection site bruising is found to be associated with 1,633 drugs and 985 conditions by eHealthMe.

Number of Saxenda and Injection site bruising reports submitted per year:

Could Saxenda cause Injection site bruising?

Time on Saxenda when people have Injection site bruising *:

Gender of people who have Injection site bruising when taking Saxenda *:

female: 93.55 %
male: 6.45 %

Age of people who have Injection site bruising when taking Saxenda *:

Common drugs people take besides Saxenda *:

Common side effects people have besides Injection site bruising *:

Injection Site Pain: 18 people, 19.35%
Injection Site Erythema (redness at injection site): 14 people, 15.05%
Injection Site Pruritus (severe itching at injection site): 13 people, 13.98%
Nausea (feeling of having an urge to vomit): 12 people, 12.90%
Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 8 people, 8.60%
Injection Site Urticaria (rash of round, red welts on the skin at injection site): 8 people, 8.60%
Injection Site Swelling: 7 people, 7.53%
Constipation: 6 people, 6.45%
Injection Site Rash: 5 people, 5.38%
Weight Increased: 5 people, 5.38%

Common conditions people have *:

Weight Decreased: 34 people, 36.56%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 2.15%
Type 2 Diabetes: 1 person, 1.08%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 1 person, 1.08%
Neuralgia (pain in one or more nerves): 1 person, 1.08%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 1.08%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 1.08%
Asthma: 1 person, 1.08%
Abnormal Weight Gain: 1 person, 1.08%

* Approximation only. Some reports may have incomplete information.

Do you take Saxenda and have Injection site bruising?

Check whether Injection site bruising is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Injection site bruising and when was it recovered:

Injection site bruising in Saxenda

Expand to all the drugs that have ingredients of liraglutide recombinant:

Injection site bruising and drugs with ingredients of liraglutide recombinant (90 reports)

Alternative drugs to, pros and cons of Saxenda:

Saxenda (5,234 reports)

Common Saxenda side effects:

Nausea and vomiting: 427 reports
Diarrhea: 280 reports
Drug ineffective: 279 reports
Fatigue (feeling of tiredness): 262 reports
Weight loss: 257 reports
Headache (pain in head): 244 reports
Constipation: 234 reports
Weight increased: 222 reports

Browse all side effects of Saxenda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Injection site bruising treatments and more:

Injection site bruising (64,549 reports)

COVID vaccines that are related to Injection site bruising:

Common drugs associated with Injection site bruising:

All the drugs that are associated with Injection site bruising:

Injection site bruising (1,633 drugs)

Common conditions associated with Injection site bruising:

All the conditions that are associated with Injection site bruising:

Injection site bruising (985 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on liraglutide recombinant (the active ingredients of Saxenda) and Saxenda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.